← Browse by Condition
Medical Condition

untreated advanced or metastatic gastric gastroesophageal junction or esophageal adenocarcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2, Phase 3
NCT07221149 Phase 2, Phase 3
Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Enrollment
690 pts
Location
United States, Argen...
Sponsor
Bristol-Myers Squibb
View Trial →